AI summary by TwinMind
129. How to Fix Medical Research | People I (Mostly) Admire
Freakonomics Radio Network
55m 43s
Background and Early Life
- Monica Bertoli: surgeon by training, former head of National Cancer Institute, current NIH Director
- Grew up on cattle ranch in Wyoming at 9,000 ft elevation in Wind Mountains
- 18 miles dirt road to highway, 98 miles from nearest town (Rock Springs)
- Family moved to town during school year
- First-generation immigrant parents
- Ranch work: raising sheep then cattle, vaccinating lambs at age 9-10
- Favorite activity: reading books indoors when it rained
Education and Career Path
- Originally planned University of Wyoming with full scholarship
- Princeton recruited her senior year - goal of 2 freshmen per state
- Applied without interview/visit, accepted early decision January
- Medical school: University of Utah, <10 women in class of 100 (1985)
- Only woman in class to pursue surgery
- Now surgery training programs are 50% women
- Faced discrimination: told she was "taking spot that belongs to man"
- Responded with determination and silence, found supportive mentors
Surgery to Leadership Transition
- "Surgeons are born not made" - instant connection to OR on first day
- Originally interested in internal medicine and laboratory work
- Surgery rotation changed everything - "didn't look back"
- Transition from OR to boardroom was "very hard"
- Still remembers feeling of first day in operating room
NIH Overview and Structure
- Largest biomedical research institute globally
- 27 institutes and centers covering all biomedical research aspects
- $50 billion budget, ~20,000 employees
- 1% of total US healthcare spending ($4.5 trillion)
- Private pharma spends ~$100 billion R&D
- Combined biomedical research = 3% of healthcare spending
- 10% NIH budget stays internal, 90% goes to external academic institutions worldwide
Healthcare Costs and Innovation
- US healthcare costs: 6% GDP (1970) → 17% GDP (current)
- US spends more per capita than any nation but life expectancy declining
- NIH goal: improve health regardless of economics
- Example: Sickle cell treatments cost $2-3 million but researchers focused on cure first, affordability second
- NIH doesn't set treatment costs but provides outcome data for private sector decisions
Clinical Research Bottleneck
- "Fire hose vs garden hose" analogy: abundant basic research vs limited clinical trials capacity
- Pharma funding for clinical trials dramatically increased
- Government clinical trial funding remained static/declined
- Physicians nationwide "clamoring for more clinical research"
- Example: NCORP (National Community Oncology Research Program) - private practice doctors wanting trials
- Capacity (patients/doctors) much greater than funding availability
- NIH budget fully committed to ongoing long-term projects
Learning Health System Initiative
- Goal: use electronic health records for continuous research feedback loop
- Transform patient experience into research data benefiting others
- Currently linear: discovery → journal → clinic application
- Missing feedback loop from clinical outcomes back to research
- Cystic Fibrosis Foundation model: national clearinghouse led to breakthrough treatments
- Life expectancy increased from 5-10 years to near-normal with proper treatment
Data Collection and Privacy Challenges
- Need patient permission and engagement for meaningful research
- Current concern: "Why should anybody have my health data without permission?"
- Vision: nationwide opt-in system where patients can contribute data and be contacted about relevant findings
- Challenges: distrust in medicine, stigmatized conditions (substance abuse, HIV)
- HIPAA creates institutional risk aversion inhibiting research
- Patient advocacy groups uniformly demand data use and results communication
- Lawyers worry about data breaches vs patients wanting participation
Political Challenges
- Approach: meet people where they are, not dictate beliefs
- Focus on individual patient needs rather than political considerations
- Example: vaccination discussions - explain science, ask about concerns and needs
- "Small politics" - person-by-person engagement
- NIH must serve everyone regardless of political views
Cancer Moonshot Initiative
- Goal: 50% reduction in age-adjusted cancer mortality within 25 years
- Assessment: "possible but difficult"
- Requires progress on multiple fronts:
- Eliminate cancer care disparities
- Reduce smoking, alcohol use, obesity
- Develop better treatments
- Current trajectory insufficient - need accelerated progress
- Lifestyle/prevention major lever but requires comprehensive approach across all areas
Personal Cancer Experience
- Diagnosed with early-stage breast cancer shortly after becoming NCI Director
- HR-positive, HER2-negative breast cancer
- Realized >100,000 women participated in clinical trials for treatments she received
- Millions of women contributed through clinical trial participation
- Made diagnosis public to support other women with similar diagnoses
- Natural optimist approach - "glass half full" perspective
- Felt obligation to be public about diagnosis rather than hide it
Breakthrough Technologies
- Nanobodies: tiny proteins from camels/sharks that fit into cellular grooves
- Potential for immune system targeting and drug delivery
- Immune system governs inflammation, tumor fighting, neurodegeneration, infection response
- Women's autoimmune disease research: X-chromosome silencing proteins drive immune response
- Stanford research: introduced silencing proteins into male animals created autoimmune disease
- Identifies new targets for autoimmune disease treatment
NIH-Pharma Collaboration
- Accelerating Medicines Partnership: direct NIH-pharma collaboration
- Small business innovation program: substantial NIH budget portion
- Intramural program focus: areas industry won't pursue independently
- Rare disease challenge: high costs due to small patient populations
- Sickle cell example: $2M treatment cost vs lifetime disease management costs
- Need partnership for successful delivery to patients
